The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Curcumin Modulates α-Synuclein Aggregation and Toxicity
Open accessAbstract
In human beings, Parkinson's disease (PD) is associated with the oligomerization and amyloid formation of α-synuclein (α-Syn). The polyphenolic Asian food ingredient curcumin has proven to be effective against a wide range of human diseases including cancers and neurological disorders. While curcumin has been shown to significantly reduce cell toxicity of α-Syn aggregates, its mechanism of action remains unexplored. Here, using a series of biophysical techniques, we demonstrate that curcumin reduces toxicity by binding to preformed oligomers and fibrils and altering their hydrophobic surface exposure. Further, our fluorescence and two-dimensional nuclear magnetic resonance (2D-NMR) data indicate that curcumin does not bind to monomeric α-Syn but binds specifically to oligomeric intermediates. The degree of curcumin binding correlates with the extent of α-Syn oligomerization, suggesting that the ordered structure of protein is required for effective curcumin binding. The acceleration of aggregation by curcumin may decrease the population of toxic oligomeric intermediates of α-Syn. Collectively; our results suggest that curcumin and related polyphenolic compounds can be pursued as candidate drug targets for treatment of PD and other neurological diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Vermes, I., Haanen, C., Steffens-Nakken, H., & Reutellingsperger, C. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00072-i · Cited by 5,410
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Conway, K. A., Lee, S.-J., Rochet, J.-C., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,541
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
In vivo demonstration that α-synuclein oligomers are toxic
Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,463
Self-citationEGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,434
Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,090
Functional Amyloids As Natural Storage of Peptide Hormones in Pituitary Secretory Granules
Maji, S. K., Perrin, M. H., Sawaya, M. R., Jessberger, S., Vadodaria, K., Rissman, R. A., Singru, P. S., Nilsson, K. P. R., Simon, R., Schubert, D., et al. (2009) · Science · doi:10.1126/science.1173155 · Cited by 1,048
Self-citationEGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., & Wanker, E. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910723107 · Cited by 1,011
Porat, Y., Abramowitz, A., & Gazit, E. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00318.x · Cited by 989
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Cremades, N., Cohen, S. I. A., Deas, E., Abramov, A. Y., Chen, A. Y., Orte, A., Sandal, M., Clarke, R. W., Dunne, P., Aprile, F. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.037 · Cited by 911
Therapeutic approaches to protein-misfolding diseases
Cohen, F. E., & Kelly, J. W. (2003) · Nature · doi:10.1038/nature02265 · Cited by 800
Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding
Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H., Hengerer, B., & Kostka, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2617-07.2007 · Cited by 765
Necula, M., Kayed, R., Milton, S., & Glabe, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608207200 · Cited by 680
THE BIOCHEMISTRY OF PARKINSON'S DISEASE
Cookson, M. R. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133400 · Cited by 664
Garcia‐Alloza, M., Borrelli, L. A., Rozkalne, A., Hyman, B. T., & Bacskai, B. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04613.x · Cited by 661
Hudson, S. A., Ecroyd, H., Kee, T. W., & Carver, J. A. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07307.x · Cited by 610
Nile red as a polarity-sensitive fluorescent probe of hydrophobic protein surfaces
Sackett, D. L., & Wolff, J. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90157-6 · Cited by 591
Zhao, H., Joseph, J., Fales, H. M., Sokoloski, E. A., Levine, R. L., Vasquez-Vivar, J., & Kalyanaraman, B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501719102 · Cited by 576
A causative link between the structure of aberrant protein oligomers and their toxicity
Campioni, S., Mannini, B., Zampagni, M., Pensalfini, A., Parrini, C., Evangelisti, E., Relini, A., Stefani, M., Dobson, C. M., Cecchi, C., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.283 · Cited by 552
The fold of α-synuclein fibrils
Vilar, M., Chou, H.-T., Lührs, T., Maji, S. K., Riek-Loher, D., Verel, R., Manning, G., Stahlberg, H., & Riek, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712179105 · Cited by 541
Self-citationCurcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity
Rai, D., Singh, J. K., Roy, N., & Panda, D. (2008) · Biochemical Journal · doi:10.1042/bj20070891 · Cited by 523
Neuroprotective effects of curcumin
Cole, G. M., Teter, B., & Frautschy, S. A. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_8 · Cited by 516
The Flavonoid Baicalein Inhibits Fibrillation of α-Synuclein and Disaggregates Existing Fibrils
Zhu, M., Rajamani, S., Kaylor, J., Han, S., Zhou, F., & Fink, A. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403129200 · Cited by 473
Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson’s disease?
Goldberg, M. S., & Lansbury Jr, P. T. (2000) · Nature Cell Biology · doi:10.1038/35017124 · Cited by 458
REVIEW: Curcumin and Alzheimer’s disease
Hamaguchi, T., Ono, K., & Yamada, M. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00147.x · Cited by 450
Clearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway
Lee, H.-J., Khoshaghideh, F., Patel, S., & Lee, S.-J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3809-03.2004 · Cited by 445
Karpinar, D. P., Balija, M. B. G., Kügler, S., Opazo, F., Rezaei‐Ghaleh, N., Wender, N., Kim, H., Taschenberger, G., Falkenburger, B. H., Heise, H., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.257 · Cited by 432
Self-citationThe Oligomerization of Amyloid β-Protein Begins Intracellularly in Cells Derived from Human Brain
Walsh, D. M., Tseng, B. P., Rydel, R. E., Podlisny, M. B., & Selkoe, D. J. (2000) · Biochemistry · doi:10.1021/bi001048s · Cited by 401
Hamaguchi, T., Ono, K., Murase, A., & Yamada, M. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090417 · Cited by 398
ANS Binding Reveals Common Features of Cytotoxic Amyloid Species
Bolognesi, B., Kumita, J. R., Barros, T. P., Esbjorner, E. K., Luheshi, L. M., Crowther, D. C., Wilson, M. R., Dobson, C. M., Favrin, G., & Yerbury, J. J. (2010) · ACS Chemical Biology · doi:10.1021/cb1001203 · Cited by 389
Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., & Selkoe, D. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9564 · Cited by 370
Small Molecule Inhibitors of α-Synuclein Filament Assembly
Masuda, M., Suzuki, N., Taniguchi, S., Oikawa, T., Nonaka, T., Iwatsubo, T., Hisanaga, S.-I., Goedert, M., & Hasegawa, M. (2006) · Biochemistry · doi:10.1021/bi0600749 · Cited by 365
Neumann, M., Kahle, P. J., Giasson, B. I., Ozmen, L., Borroni, E., Spooren, W., Müller, V., Odoy, S., Fujiwara, H., Hasegawa, M., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15777 · Cited by 355
Kinetic Studies of Amyloid β-Protein Fibril Assembly
Fezoui, Y., & Teplow, D. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204168200 · Cited by 342
Ono, K., & Yamada, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03707.x · Cited by 320
Klunk, W. E., Jacob, R. F., & Mason, R. P. (1999) · Analytical Biochemistry · doi:10.1006/abio.1998.2933 · Cited by 310
Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
Caruana, M., Högen, T., Levin, J., Hillmer, A., Giese, A., & Vassallo, N. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.046 · Cited by 273
Curcumin inhibits aggregation of α-synuclein
Pandey, N., Strider, J., Nolan, W. C., Yan, S. X., & Galvin, J. E. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0332-4 · Cited by 263
Volles, M. J., & Lansbury, P. T. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.12.044 · Cited by 248
Munishkina, L. A., Phelan, C., Uversky, V. N., & Fink, A. L. (2003) · Biochemistry · doi:10.1021/bi027166s · Cited by 247
Soluble Aβ Seeds Are Potent Inducers of Cerebral β-Amyloid Deposition
Langer, F., Eisele, Y. S., Fritschi, S. K., Staufenbiel, M., Walker, L. C., & Jucker, M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3088-11.2011 · Cited by 237
Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
Wang, M. S., Boddapati, S., Emadi, S., & Sierks, M. R. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-57 · Cited by 197
El-Agnaf, O. M. A., Paleologou, K. E., Greer, B., Abogrein, A. M., King, J. E., Salem, S. A., Fullwood, N. J., Benson, F. E., Hewitt, R., Ford, K. J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1346fje · Cited by 187
Uversky, V. N., Lee, H.-J., Li, J., Fink, A. L., & Lee, S.-J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100551200 · Cited by 186
Curcumin Prevents Aggregation in α-Synuclein by Increasing Reconfiguration Rate
Ahmad, B., & Lapidus, L. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.325548 · Cited by 184
Structural Characteristics of α-Synuclein Oligomers Stabilized by the Flavonoid Baicalein
Hong, D.-P., Fink, A. L., & Uversky, V. N. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.039 · Cited by 177
Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation
Anderson, V. L., Ramlall, T. F., Rospigliosi, C. C., Webb, W. W., & Eliezer, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012336107 · Cited by 172
Ferreira, N., Saraiva, M. J., & Almeida, M. R. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.06.030 · Cited by 164
Dairam, A., Fogel, R., Daya, S., & Limson, J. L. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0734931 · Cited by 159
Liu, Z., Yu, Y., Li, X., Ross, C. A., & Smith, W. W. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.01.004 · Cited by 152
Aggregation and neurotoxicity of α-synuclein and related peptides
EI-Agnaf, O. M. A., & Irvine, G. B. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300559 · Cited by 151
Curcumin Promotes A-beta Fibrillation and Reduces Neurotoxicity in Transgenic Drosophila
Caesar, I., Jonson, M., Nilsson, K. P. R., Thor, S., & Hammarström, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031424 · Cited by 151
Hickey, M. A., Zhu, C., Medvedeva, V. P., Lerner, R. P., Patassini, S., Franich, N. R., Maiti, P., Frautschy, S. A., Zeitlin, S. O., Levine, M. S., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-12 · Cited by 136
Black Tea Theaflavins Inhibit Formation of Toxic Amyloid-β and α-Synuclein Fibrils
Grelle, G., Otto, A., Lorenz, M., Frank, R. F., Wanker, E. E., & Bieschke, J. (2011) · Biochemistry · doi:10.1021/bi2012383 · Cited by 133
Hafner‐Bratkovič, I., Gašperšič, J., Šmid, L. M., Bresjanac, M., & Jerala, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05105.x · Cited by 127
Design strategies for anti-amyloid agents
Mason, J. M., Kokkoni, N., Stott, K., & Doig, A. J. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(03)00100-3 · Cited by 127
Genetics of Parkinson's disease and biochemical studies of implicated gene products
Lansbury, P. T., & Brice, A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00302-7 · Cited by 120
Martin, Z. S., Neugebauer, V., Dineley, K. T., Kayed, R., Zhang, W., Reese, L. C., & Taglialatela, G. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07576.x · Cited by 117
The Role of α‐Synuclein in Both Neuroprotection and Neurodegeneration
Sidhu, A., Wersinger, C., Moussa, C., & Vernier, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.016 · Cited by 115
Lamberto, G. R., Binolfi, A., Orcellet, M. L., Bertoncini, C. W., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902603106 · Cited by 113
Khuwaja, G., Khan, M. M., Ishrat, T., Ahmad, A., Raza, S. S., Ashafaq, M., Javed, H., Khan, M. B., Khan, A., Vaibhav, K., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.023 · Cited by 95
Braga, C. A. C. A., Follmer, C., Palhano, F. L., Khattar, E., de Freitas, M. S., Romão, L. F., Giovanni, S. D., Lashuel, H. A., Silva, J. L., & Foguel, D. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.10.027 · Cited by 94
Characterization of α-Synuclein Interactions with Selected Aggregation-Inhibiting Small Molecules
Rao, J. N., Dua, V., & Ulmer, T. S. (2008) · Biochemistry · doi:10.1021/bi8002378 · Cited by 86
Daban, J., Samsó, M., & Bartolomé, S. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90084-7 · Cited by 73
A Chemical Analog of Curcumin as an Improved Inhibitor of Amyloid Abeta Oligomerization
Orlando, R. A., Gonzales, A. M., Royer, R. E., Deck, L. M., & Jagt, D. L. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031869 · Cited by 72
Amijee, H., Bate, C., Williams, A., Virdee, J. K., Jeggo, R., Spanswick, D. C., Scopes, D. I. C., Treherne, J. M., Mazzitelli, S., Chawner, R., et al. (2012) · Biochemistry · doi:10.1021/bi300415v · Cited by 72
Genetics of Parkinson's disease and biochemical studies of implicated gene products: Commentary
Lansbury, P. T., & Brice, A. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00377-0 · Cited by 67
Masuda, M., Hasegawa, M., Nonaka, T., Oikawa, T., Yonetani, M., Yamaguchi, Y., Kato, K., Hisanaga, S., & Goedert, M. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.01.037 · Cited by 43
Studying Human Neurodegenerative Diseases in Flies and Worms
Feany, M. Β. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.10.847 · Cited by 35
Lazo, N. D., Maji, S. K., Fradinger, E. A., Bitan, G., & Teplow, D. B. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch17 · Cited by 18
Self-citation
Cited by
α‐Synuclein aggregation nucleates through liquid‐liquid phase separation
Ray, S., Singh, N., Kumar, R., Patel, K., Pandey, S., Datta, D., Mahato, J., Panigrahi, R., Navalkar, A., Mehra, S., et al. (2020) · Nature Chemistry · doi:10.1038/s41557-020-0465-9 · Cited by 863
Self-citationSavelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Maiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 525
α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
Mehra, S., Sahay, S., & Maji, S. K. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.03.001 · Cited by 499
Self-citationPeng, H., Li, Y., Ji, W., Zhao, R., Lu, Z., Shen, J., Wu, Y., Wang, J., Hao, Q., Wang, J., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c08473 · Cited by 205
Metadata
- Authors
- Singh, P. K., Kotia, V., Ghosh, D., Mohite, G. M., Kumar, A., & Maji, S. K.
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-12-17
- Volume
- 4
- Issue
- 3
- Pages
- 393-407
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W2041037209
- Cited by
- 307
- References
- 75
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.